Trial Designs For Non-Cystic Fibrosis Bronchiectasis May Need Refinement
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA public workshop will consider the design of clinical studies testing antibacterial drugs to treat lung damage caused by recurrent infections.